Dopaminergic medication reduces striatal sensitivity to negative outcomes in Parkinson’s disease
Brónagh McCoy, Sara Jahfari, Gwenda Engels, Tomas H. J. Knapen, Jan Theeuwes
This study shows that dopaminergic medication in Parkinson’s disease reduces striatal sensitivity to negative outcomes during learning and affects subsequent approach/avoidance behavior.
Brain · Aug 31, 2019Peer-reviewedNeuroscience